Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Cell Surface | 8 | 2020 | 69 | 1.950 |
Why?
|
| Proton-Translocating ATPases | 3 | 2019 | 16 | 1.020 |
Why?
|
| Neurons | 7 | 2020 | 417 | 0.870 |
Why?
|
| Angiotensin II | 5 | 2017 | 245 | 0.820 |
Why?
|
| Hypertension | 6 | 2019 | 983 | 0.800 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2023 | 3 | 0.780 |
Why?
|
| Thyroid Diseases | 1 | 2023 | 6 | 0.780 |
Why?
|
| Fibroadenoma | 1 | 2021 | 2 | 0.710 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 4 | 0.640 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 158 | 0.630 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 429 | 0.610 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2019 | 8 | 0.610 |
Why?
|
| Blood Pressure | 7 | 2020 | 867 | 0.580 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2017 | 2 | 0.580 |
Why?
|
| Renin-Angiotensin System | 3 | 2018 | 178 | 0.560 |
Why?
|
| Renin | 4 | 2020 | 109 | 0.510 |
Why?
|
| CREB-Binding Protein | 1 | 2015 | 4 | 0.460 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 754 | 0.450 |
Why?
|
| Hypertension, Renal | 1 | 2013 | 29 | 0.410 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 28 | 0.410 |
Why?
|
| Peptide Fragments | 1 | 2014 | 410 | 0.360 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 355 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 790 | 0.300 |
Why?
|
| Phosphorylation | 4 | 2019 | 226 | 0.280 |
Why?
|
| Hypothalamus | 2 | 2020 | 18 | 0.270 |
Why?
|
| Animals | 12 | 2020 | 7598 | 0.270 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2019 | 65 | 0.260 |
Why?
|
| Calcium Signaling | 2 | 2019 | 46 | 0.250 |
Why?
|
| Retrospective Studies | 4 | 2022 | 3708 | 0.240 |
Why?
|
| Central Nervous System | 2 | 2017 | 43 | 0.230 |
Why?
|
| Sodium Chloride | 2 | 2015 | 21 | 0.230 |
Why?
|
| Humans | 14 | 2023 | 32952 | 0.220 |
Why?
|
| Mice, Knockout | 5 | 2020 | 458 | 0.220 |
Why?
|
| Mice | 6 | 2020 | 2528 | 0.220 |
Why?
|
| Inflammation | 2 | 2020 | 542 | 0.200 |
Why?
|
| Bone Marrow | 2 | 2013 | 72 | 0.200 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2022 | 9 | 0.190 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 7 | 0.190 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 40 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2019 | 34 | 0.180 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 33 | 0.180 |
Why?
|
| Metaplasia | 1 | 2021 | 19 | 0.180 |
Why?
|
| Sarcoma | 1 | 2022 | 71 | 0.180 |
Why?
|
| Exosomes | 1 | 2022 | 45 | 0.170 |
Why?
|
| Mutation | 2 | 2022 | 499 | 0.170 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 497 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1015 | 0.160 |
Why?
|
| Astrocytes | 1 | 2020 | 57 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 217 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2022 | 190 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 526 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 225 | 0.150 |
Why?
|
| Sodium, Dietary | 1 | 2018 | 23 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2017 | 191 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 209 | 0.140 |
Why?
|
| Autonomic Nervous System | 2 | 2019 | 44 | 0.140 |
Why?
|
| Strongyloidiasis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 192 | 0.140 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 19 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2020 | 495 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 727 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2017 | 689 | 0.130 |
Why?
|
| Cell Line | 2 | 2015 | 436 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 164 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 647 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 19 | 0.110 |
Why?
|
| Binding Sites | 1 | 2015 | 129 | 0.110 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2015 | 2 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 77 | 0.110 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 65 | 0.110 |
Why?
|
| Ion Transport | 1 | 2014 | 5 | 0.110 |
Why?
|
| Captopril | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cerebral Arteries | 1 | 2015 | 19 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 33 | 0.110 |
Why?
|
| Transfection | 1 | 2015 | 185 | 0.110 |
Why?
|
| Losartan | 1 | 2014 | 64 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2014 | 31 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 136 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2015 | 61 | 0.110 |
Why?
|
| Vasodilation | 1 | 2015 | 93 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 79 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 117 | 0.110 |
Why?
|
| Baroreflex | 1 | 2014 | 86 | 0.100 |
Why?
|
| Mineralocorticoids | 1 | 2013 | 5 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 46 | 0.100 |
Why?
|
| Female | 4 | 2021 | 20363 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2015 | 500 | 0.100 |
Why?
|
| Calcium | 1 | 2014 | 323 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 265 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2013 | 241 | 0.090 |
Why?
|
| Organoids | 2 | 2022 | 98 | 0.090 |
Why?
|
| Male | 6 | 2022 | 19743 | 0.080 |
Why?
|
| Time Factors | 1 | 2015 | 2195 | 0.080 |
Why?
|
| Rats | 3 | 2015 | 1610 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 98 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 11 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 54 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 59 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2022 | 43 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2022 | 94 | 0.040 |
Why?
|
| Neutrophils | 1 | 2022 | 110 | 0.040 |
Why?
|
| Hydrogels | 1 | 2022 | 126 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2022 | 220 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 265 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2020 | 58 | 0.040 |
Why?
|
| Nicotine | 1 | 2022 | 177 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 894 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 74 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
| Potassium | 1 | 2018 | 40 | 0.040 |
Why?
|
| Body Weight | 1 | 2020 | 302 | 0.040 |
Why?
|
| Food Preferences | 1 | 2018 | 35 | 0.040 |
Why?
|
| Synapsins | 1 | 2017 | 2 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 1852 | 0.030 |
Why?
|
| Strongyloides stercoralis | 1 | 2017 | 3 | 0.030 |
Why?
|
| Piperacillin | 1 | 2017 | 6 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2017 | 6 | 0.030 |
Why?
|
| Antiparasitic Agents | 1 | 2017 | 6 | 0.030 |
Why?
|
| Ivermectin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2017 | 14 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 82 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 51 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 259 | 0.030 |
Why?
|
| Bacteremia | 1 | 2017 | 65 | 0.030 |
Why?
|
| Middle Aged | 2 | 2022 | 12202 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 32 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 32 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 332 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2015 | 80 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 255 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 290 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2013 | 19 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2013 | 32 | 0.030 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2013 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 10 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 26 | 0.030 |
Why?
|
| Minocycline | 1 | 2013 | 12 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 79 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2013 | 33 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 31 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 72 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 152 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 36 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 42 | 0.020 |
Why?
|
| Dependovirus | 1 | 2013 | 20 | 0.020 |
Why?
|
| Microglia | 1 | 2013 | 68 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 98 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 71 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 754 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 122 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 132 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 247 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 336 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 392 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 9586 | 0.020 |
Why?
|